Cargando…

Management of inflammatory rheumatic conditions in the elderly

The number of elderly people with chronic inflammatory rheumatic diseases is increasing. This heterogeneous and comorbid population is at particular risk of cardiovascular, neoplastic, infectious and iatrogenic complications. The development of biotherapies has paved the way for innovative therapeut...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lahaye, Clément, Tatar, Zuzana, Dubost, Jean-Jacques, Tournadre, Anne, Soubrier, Martin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Reviews
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477520/ https://www.ncbi.nlm.nih.gov/pubmed/29982766 http://dx.doi.org/10.1093/rheumatology/key165

Ejemplares similares

Characteristics of spontaneous coagulase-negative staphylococcal spondylodiscitis: a retrospective comparative study versus Staphylococcus aureus spondylodiscitis
por: Lopez, Julien, et al.
Publicado: (2017)

Prevalence of Migraine and Neuropathic Pain in Rheumatic Diseases
por: Mathieu, Sylvain, et al.
Publicado: (2020)

Retention rates of adalimumab, etanercept, and infliximab as first‐ or second‐line biotherapies for spondyloarthritis patients in daily practice in Auvergne (France)
por: Soubrier, Martin, et al.
Publicado: (2018)

Effects of 6 months of abatacept treatment on aortic stiffness in patients with rheumatoid arthritis
por: Mathieu, Sylvain, et al.
Publicado: (2013)

Construction and utilization of a script concordance test as an assessment tool for dcem3 (5th year) medical students in rheumatology
por: Mathieu, Sylvain, et al.
Publicado: (2013)

Soluble IL-2 Receptor: A Biomarker for Assessing Myositis Activity
por: Tournadre, Anne, et al.
Publicado: (2014)

Prevalence and risk factors of low bone mineral density in spondyloarthritis and prevalence of vertebral fractures
por: Malochet-Guinamand, Sandrine, et al.
Publicado: (2017)

Vascular endothelial growth factor levels and rheumatic diseases of the elderly
por: Smets, Perrine, et al.
Publicado: (2016)

A Meta-Analysis of the Impact of Nutritional Supplementation on Osteoarthritis Symptoms
por: Mathieu, Sylvain, et al.
Publicado: (2022)

Efficacy and safety of pamidronate in Modic type 1 changes: study protocol for a prospective randomized controlled clinical trial
por: Cecchetti, Stella, et al.
Publicado: (2014)

Omega 3 Fatty Acids Intake Does Not Decrease the Risk of Rheumatoid Arthritis Occurrence: A Meta-Analysis. Comment on Tański et al. The Relationship between Fatty Acids and the Development, Course and Treatment of Rheumatoid Arthritis. Nutrients 2022, 14, 1030
por: Mathieu, Sylvain, et al.
Publicado: (2023)

Efficacy of Oral Vitamin Supplementation in Inflammatory Rheumatic Disorders: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
por: Nguyen, Yann, et al.
Publicado: (2020)

Adherence to Subcutaneous Anti-TNF Treatment in Chronic Inflammatory Rheumatism and Therapeutic Patient Education
por: Fayet, Françoise, et al.
Publicado: (2020)

Refractory Rheumatic Disorder: Atypical Postpregnancy Osteoporosis
por: Mourgues, Cindy, et al.
Publicado: (2015)

The Importance of Outcome Measures in the Management of Inflammatory Rheumatic Diseases
por: Molina Collada, Juan, et al.
Publicado: (2021)

Role of adalimumab in the management of children and adolescents with juvenile idiopathic arthritis and other rheumatic conditions
por: Marzan, Katherine Anne B
Publicado: (2012)

Multimorbidity in rheumatic conditions
por: Radner, Helga
Publicado: (2016)

Assessment of the risk factors for impending fractures following radiotherapy for long bone metastases using CT scan-based virtual simulation: a retrospective study
por: Tatar, Zuzana, et al.
Publicado: (2014)

Editorial: Chronic rheumatic inflammatory conditions and cardiovascular health
por: Lo Gullo, Alberto, et al.
Publicado: (2022)

Coronavirus and quarantine: will we sacrifice our elderly to protect them?
por: Bouillon-Minois, Jean-Baptiste, et al.
Publicado: (2020)

Outcome measures in inflammatory rheumatic diseases
por: Fransen, Jaap, et al.
Publicado: (2009)

COVID-19, chronic inflammatory rheumatic disease and anti-rheumatic treatments
por: Ouédraogo, Dieu-Donné, et al.
Publicado: (2020)

Measuring quality of life in rheumatic conditions
por: Walker, Janine G., et al.
Publicado: (2006)

Impact of type and dose of oral polyunsaturated fatty acid supplementation on disease activity in inflammatory rheumatic diseases: a systematic literature review and meta-analysis
por: Sigaux, Johanna, et al.
Publicado: (2022)

Agranulocytosis under biotherapy in rheumatoid arthritis: three cases hypothesis of parvovirus B19 involvement in agranulocytosis observed under tocilizumab and rituximab for the treatment of rheumatoid arthritis
por: Giraud, C., et al.
Publicado: (2016)

Utility of (18)F-Fluorodeoxyglucose Positron Emission Tomography in Inflammatory Rheumatism, Particularly Polymyalgia Rheumatica: A Retrospective Study of 222 PET/CT
por: Amat, Julie, et al.
Publicado: (2020)

Assessment of Intramuscular Fat and Correlation with Body Composition in Patients with Rheumatoid Arthritis and Spondyloarthritis: A Pilot Study
por: Villedon de Naide, Marc, et al.
Publicado: (2021)

Variations in the metabolome in response to disease activity of rheumatoid arthritis
por: Tatar, Zuzana, et al.
Publicado: (2016)

Potential Mechanism of Fatigue Induction and Its Management by JAK Inhibitors in Inflammatory Rheumatic Diseases
por: Felis-Giemza, Anna, et al.
Publicado: (2023)

Latent Rheumatic Conditions
por: Phelan, J. R.
Publicado: (1906)

Fatigue in inflammatory rheumatic disorders: pathophysiological mechanisms
por: Korte, S Mechiel, et al.
Publicado: (2019)

Conditions in subjects with rheumatic diseases: pulmonary manifestations of vasculitides
por: Holle, Julia U, et al.
Publicado: (2011)

Systemic Inflammatory Response and Atherosclerosis: The Paradigm of Chronic Inflammatory Rheumatic Diseases
por: Arida, Aikaterini, et al.
Publicado: (2018)

Perceived barriers to the management of foot health in patients with rheumatic conditions
por: Lansdowne, Nina, et al.
Publicado: (2015)

Treatment of Inflammatory Rheumatism
por: Gibbs, O. C.
Publicado: (1854)

Role of inflammasomes in inflammatory autoimmune rheumatic diseases
por: Yi, Young-Su
Publicado: (2018)

The Effect of TNF and Non-TNF-Targeted Biologics on Body Composition in Rheumatoid Arthritis
por: Vial, Gaelle, et al.
Publicado: (2021)

The Influence of Adipokines on Radiographic Damage in Inflammatory Rheumatic Diseases
por: Toussirot, Eric
Publicado: (2023)

Reducing fatigue in pediatric rheumatic conditions: a systematic review
por: Kant-Smits, K., et al.
Publicado: (2021)

Implications of COVID-19 for the management of patients with inflammatory rheumatic diseases
por: Richez, Christophe, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ltjbet5eo1t6d5l788e4gak2ep